CELZ-201-DDT is a regenerative stem cell-based therapy being developed as a potential treatment for chronic low back pain associated with degenerative disc disease.

HealthDay News — Mailing a stool-based test directly to people’s homes is the most effective strategy for increasing colorectal cancer screening rates, according to a study published online August 4 ...

"If you see increased wastewater viral activity levels, it might indicate that there is a higher risk of infection." ...

HealthDay News — Metformin use is associated with lower risks for dementia and all-cause mortality across body mass index (BMI) groups in patients with overweight or obesity, according to a study ...

Patients with postural orthostatic tachycardia syndrome treated with ivabradine have better heart-rate control when standing.

HealthDay News — Most individuals living in underserved communities believe that dermatologic side effects (DSEs) from anticancer therapies (ACTs) occur at high rates, according to a study published ...

GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR.

For infants less than 8 months of age born during or entering their first RSV season and not otherwise protected through maternal vaccination, nirsevimab is considered the first-line recommended ...

Ianalumab added to eltrombopag significantly prolonged the time to treatment failure (TTF) in adults with primary immune thrombocytopenia (ITP), a B cell-driven autoimmune disease, according to phase ...

Cylembio is a therapeutic cancer vaccine candidate that targets cells and immune-suppressive cells in the tumor microenvironment through activation and expansion of T cells against IDO1 and/or PD-L1 ...

Approved in 2022, Skysona is indicated to slow the progression of neurologic dysfunction in boys 4 to 17 years of age with early, active cerebral adrenoleukodystrophy.

The KEYNOTE-905 study is ongoing and will evaluate other endpoints including EFS, OS, and pCR rate for neoadjuvant and adjuvant pembrolizumab vs surgery alone.